• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Texas

Eli Lilly Houston Generation Park
Manufacturing

Lilly reveals plans for $6.5B API production facility in Texas

Eli Lilly has revealed that it will build a $6.5 billion plant in Houston to produce active pharmaceutical ingredients for oral drugs.
Kevin Dunleavy Sep 23, 2025 1:00pm
Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

Texas has sued Eli Lilly over an alleged kickback scheme

Aug 12, 2025 4:26pm
Houston Texas Houston TX

Lilly weighs Houston as option for new $5.9B API facility

May 19, 2025 10:21am
FDA

Compounder in Lilly lawsuit hit with FDA warning letter

Apr 24, 2025 8:20am
AZ

AZ tacks on $2B to its investment in US manufacturing, R&D

Nov 12, 2024 10:10am
drug launch launch takeoff

IntraBio snags FDA nod in rare disease just days after Zevra

Sep 25, 2024 9:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings